Global Health Share Price
Global Health Share Price Today
As of 5 Jul 2026, Global Health share price is ₹1,350.70. The stock opened at ₹1,349.00, compared to its previous close of ₹1,345.30. During today's trading session, Global Health share price moved in the range of ₹1,339.40 to ₹1,361.90, with an average price of ₹1,350.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹956.00 and a high of ₹1,456.50. On the performance front, Global Health share price has increased by 10.98% over the last six months and is up 13.45% on a year-on-year basis.
Global Health Returns Calculator
Global Health Shareholder Returns
Global Health Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
| DR AGARWALS HEALTH CARE L | 15,099.50 | 89.88 | 7.45 | 6.58% | 0.34 | 9.75% | 62.82 | 0.00% | 0.49 | 1.25 |
Global Health Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹3,692.32 | ₹3,275.11 | ₹2,709.88 | ₹2,166.59 |
| Other Income | ₹79.10 | ₹74.66 | ₹49.29 | ₹39.23 |
| Total Revenue | ₹3,771.41 | ₹3,349.78 | ₹2,759.16 | ₹2,205.82 |
| Total Expenses | ₹3,074.26 | ₹2,722.68 | ₹2,309.87 | ₹1,925.26 |
| Profit Before Tax | ₹647.26 | ₹627.10 | ₹449.29 | ₹280.56 |
| Tax | ₹165.94 | ₹149.04 | ₹123.21 | ₹84.36 |
| Profit After Tax | ₹481.32 | ₹478.06 | ₹326.08 | ₹196.20 |
| EPS - Basic | ₹17.92 | ₹17.80 | ₹12.58 | ₹7.78 |
| EPS - Diluted | ₹17.92 | ₹17.80 | ₹12.57 | ₹7.77 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹647.26 | ₹627.10 | ₹449.29 | ₹280.56 |
| Income before WC changes | ₹887.70 | ₹835.46 | ₹647.84 | ₹476.05 |
| Change in Assets | -₹107.89 | -₹63.46 | -₹8.31 | -₹90.62 |
| Change in Liabilities | ₹8.18 | ₹17.55 | ₹111.13 | ₹23.85 |
| Change in WC | -₹99.71 | -₹45.91 | ₹102.82 | -₹66.77 |
| Cash flow from Operations | ₹623.76 | ₹612.08 | ₹644.52 | ₹311.26 |
| Cash flow from Investing | -₹720.94 | -₹440.80 | -₹342.35 | -₹420.88 |
| Cash flow from Financing | -₹97.23 | -₹513.92 | ₹345.64 | ₹159.59 |
| Total Cash Flow | -₹194.41 | -₹342.64 | ₹647.81 | ₹49.97 |
| Cash (Start of the year) | ₹424.61 | ₹767.24 | ₹119.43 | ₹69.47 |
| Cash (End of the year) | ₹230.20 | ₹424.61 | ₹767.24 | ₹119.43 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹3,233.11 | ₹2,795.35 | ₹2,536.48 | ₹2,333.79 |
| Current Assets | ₹1,533.12 | ₹1,508.73 | ₹1,579.49 | ₹811.72 |
| Total Assets | ₹4,766.23 | ₹4,304.08 | ₹4,115.97 | ₹3,145.52 |
| Current Liabilities | ₹618.82 | ₹617.73 | ₹572.56 | ₹419.48 |
| Net Current Asset | ₹914.31 | ₹891.00 | ₹1,006.93 | ₹392.25 |
| Non-Current Liabilities | ₹759.91 | ₹780.75 | ₹1,115.20 | ₹1,110.03 |
| Equity Capital | ₹3,387.51 | ₹2,905.59 | ₹2,428.21 | ₹1,616.01 |
| Total Equity & Liabilities | ₹4,766.23 | ₹4,304.08 | ₹4,115.97 | ₹3,145.52 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹3,204.15 | ₹2,974.72 | ₹1,973.54 | ₹1,764.96 |
| Other Income | ₹90.93 | ₹90.59 | ₹47.59 | ₹35.04 |
| Total Revenue | ₹3,295.08 | ₹3,065.31 | ₹2,021.13 | ₹1,800.00 |
| Total Expenses | ₹2,622.13 | ₹2,406.46 | ₹1,669.42 | ₹1,504.17 |
| Profit Before Tax | ₹623.05 | ₹658.85 | ₹351.71 | ₹295.83 |
| Tax | ₹161.52 | ₹172.50 | ₹88.46 | ₹77.04 |
| Profit After Tax | ₹461.53 | ₹486.35 | ₹263.25 | ₹218.78 |
| EPS - Basic | ₹17.18 | ₹18.11 | ₹10.16 | ₹8.68 |
| EPS - Diluted | ₹17.18 | ₹18.11 | ₹10.15 | ₹8.66 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹623.05 | ₹658.85 | ₹351.71 | ₹295.83 |
| Income before WC changes | ₹778.32 | ₹786.39 | ₹435.01 | ₹395.68 |
| Change in Assets | -₹99.10 | -₹57.49 | ₹14.92 | -₹78.06 |
| Change in Liabilities | ₹9.18 | ₹4.21 | ₹81.55 | ₹8.57 |
| Change in WC | -₹89.92 | -₹53.28 | ₹96.47 | -₹69.49 |
| Cash flow from Operations | ₹527.67 | ₹559.38 | ₹430.53 | ₹235.40 |
| Cash flow from Investing | -₹638.20 | -₹518.87 | -₹257.29 | -₹312.99 |
| Cash flow from Financing | -₹94.49 | -₹379.49 | ₹404.22 | ₹97.59 |
| Total Cash Flow | -₹205.03 | -₹338.99 | ₹577.47 | ₹20.01 |
| Cash (Start of the year) | ₹395.09 | ₹734.08 | ₹65.31 | ₹45.31 |
| Cash (End of the year) | ₹190.07 | ₹395.09 | ₹642.78 | ₹65.31 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,987.83 | ₹2,548.41 | ₹1,780.79 | ₹1,645.22 |
| Current Assets | ₹1,452.75 | ₹1,460.15 | ₹1,397.92 | ₹716.12 |
| Total Assets | ₹4,440.59 | ₹4,008.56 | ₹3,178.70 | ₹2,361.33 |
| Current Liabilities | ₹518.83 | ₹514.75 | ₹396.64 | ₹301.92 |
| Net Current Asset | ₹933.93 | ₹945.40 | ₹1,001.27 | ₹414.19 |
| Non-Current Liabilities | ₹424.15 | ₹456.77 | ₹293.20 | ₹319.66 |
| Equity Capital | ₹3,497.61 | ₹3,037.03 | ₹2,488.86 | ₹1,739.75 |
| Total Equity & Liabilities | ₹4,440.59 | ₹4,008.56 | ₹3,178.70 | ₹2,361.33 |
About Global Health
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
Global Health Financial Highlights
- Revenue: Global Health reported revenue of ₹4,508.86 crore in FY26 vs ₹3,771.30 crore in FY25. It showed an increase of 19.56% on a yearly basis.
- Operating Profit: Global Health reported an operating profit of ₹715.02 crore in FY26 vs ₹647.26 crore in FY25. It showed an increase of 10.47% on a year-on-year basis.
- Net Profit: Global Health reported a net profit of ₹554.07 crore in FY26 vs ₹481.32 crore in FY25. It showed an increase of 15.11% on a yearly basis.
Global Health Quarterly Result Highlights
- Global Health reported revenue of ₹1,195.79 crore in Mar 2026, compared with ₹1,142.83 crore in Dec 2025, representing an increase of 4.63% on a quarter-on-quarter (QoQ) basis.
- Global Health reported an operating profit of ₹187.28 crore in Mar 2026, compared with ₹119.78 crore in Dec 2025, representing an increase of 56.35% on a quarter-on-quarter (QoQ) basis.
- Global Health reported a profit of ₹141.65 crore in Mar 2026, compared with ₹95.03 crore in Dec 2025, reflecting an increase of 49.06% on a QoQ basis.
- The earnings per share (EPS) of Global Health stood at ₹17.92 during Mar 2026.
Similar Stocks
FAQs on Global Health Share Price
What is Global Health share price today?
Global Health share price is ₹1,350.70 as on 03 Jul, 2026, 15:51 IST.
How has the Global Health share price performed in the past?
In the last 1 year, Global Health delivered a return of 13.45%. The Global Health share price hit a high of ₹1,456.50 and low of ₹956.00.
How much is the Mutual Fund shareholding in Global Health shares?
The Mutual Fund Shareholding in Global Health was 13.91% at the end of Mar 2026.
What is the the 52-week high and low of Global Health shares ?
The 52-week high and low of Global Health share is ₹1,456.50 and ₹956.00 as of 03 Jul, 2026.
What is the market cap of Global Health?
The market capitalisation of Global Health is ₹36,176.70 Crores as on 03 Jul, 2026.
What are the stock symbols of Global Health?
The stock symbol of Global Health is MEDANTA on the NSE, 543654 on the BSE, and the ISIN is INE474Q01031.
What was yesterday's closing price of Global Health shares ?
Global Health shares closed yesterday at ₹1,345.30 on NSE & ₹1,345.50 on BSE
How to buy Global Health shares?
To buy Global Health shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Global Health shares on Holidays?
No, shares of Global Health or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Global Health shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Global Health?
The PE and PB ratio of Global Health is 65.28 and 9.13 respectively, as on 03 Jul, 2026, 15:51 IST.